Sign in

CIK 0001764013 · Large accelerated filer

Immunovant, Inc.

Sign in to watch
Ticker
IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
832771572
Phone
917-410-3120
Business address
1000 PARK FORTY PLAZA, DURHAM, NC, 27713
Former names
Health Sciences Acquisitions Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,030,805
in 10 filings, $173K under 10b5-1 plans

Net −$1,030,805. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gloria Melanie −$207K Chief Operating Officer sold 2% of stake
  2. Stout Jay S −$197K Chief Technology Officer sold 3% of stake
  3. Girao Tiago −$188K Chief Financial Officer sold 3% of stake
  4. Pande Atul −$173K Director sold 4% of stake
  5. Van Tuyl Christopher −$146K Chief Legal Officer sold 2% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-04-07 Hughes Douglas J. Director Grant or award +13,880 134,653
2026-04-07 Hughes Douglas J. Director Grant or award · Stock Option (right to buy) +7,061 7,061
2026-04-07 Pande Atul Director Grant or award +13,880 116,731
2026-04-07 Pande Atul Director Grant or award · Stock Option (right to buy) +7,061 7,061
2026-04-07 Bauer Jake Director Grant or award +13,880 38,896
2026-04-07 Bauer Jake Director Grant or award · Stock Option (right to buy) +7,061 7,061
2026-04-07 Susman Robert Graham Director Grant or award +13,880 38,896
2026-04-07 Susman Robert Graham Director Grant or award · Stock Option (right to buy) +7,061 7,061
2026-04-07 Gloria Melanie Chief Operating Officer Grant or award +83,671 253,944
2026-04-07 Gloria Melanie Chief Operating Officer Grant or award · Stock Option (right to buy) +121,063 121,063
2026-04-07 Stout Jay S Chief Technology Officer Grant or award +66,937 264,571
2026-04-07 Stout Jay S Chief Technology Officer Grant or award · Stock Option (right to buy) +96,851 96,851
2026-04-07 Van Tuyl Christopher Chief Legal Officer Grant or award +41,343 188,396
2026-04-07 Van Tuyl Christopher Chief Legal Officer Grant or award · Stock Option (right to buy) +59,820 59,820
2026-04-07 Venker Eric Chief Executive Officer Grant or award +232,252 251,813
2026-04-07 Venker Eric Chief Executive Officer Grant or award · Stock Option (right to buy) +336,043 336,043
2026-04-07 Girao Tiago Chief Financial Officer Grant or award +64,968 273,356
2026-04-07 Girao Tiago Chief Financial Officer Grant or award · Stock Option (right to buy) +94,002 94,002
2026-04-02 Venker Eric Chief Executive Officer Sale −12,820 $24.04 $308K 20,970
2026-04-02 Venker Eric Chief Executive Officer Sale −1,409 $24.60 $35K 19,561

Page 5 of 10 · 191 trades